OpenLB
Open Library of Bioscience
Advanced Search
Clinical advances in hematology & oncology : H&O
Jul, 2012;10 (7): 468-71.

Advances in LLM: Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma.

Nancy L Bartlett
Author Information
  1. Nancy L Bartlett: Washington University School of Medicine, St. Louis, Missouri 63110, USA. nbartlet@dom.wustl.edu
PMID: 22895289

Abstract

No abstract text available.

Comment Journal Article

Word Cloud

Created with Highcharts 10.0.0AdvancesLLM:Brentuximabvedotinrelapsed/refractoryHodgkinlymphoma

Similar Articles

Cited By

No available data.